Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

New psoriasis treatments are effective but come with side effects and risks.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Finasteride may help treat childhood brain tumors by activating certain genes.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Ketoconazole can treat ovarian hyperandrogenism but should be used cautiously with monitoring and birth control.

Some blood donors on teratogenic drugs may have unsafe drug levels, suggesting a need for better deferral policies.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Switching to a twice-weekly betamethasone treatment led to full hair regrowth in alopecia areata without side effects.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

A woman in Turkey with a scalp infection was cured using oral and topical antifungals after a recurrence due to not following the treatment properly.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.